U.S. Paper and Forestry Products Stock News

Natural Resource Partners L.P. reported its third quarter 2025 financial results, revealing lower revenue and net income year-over-year due to ongoing weak coal and soda ash pricing, and announced a US$0.75 per unit cash distribution payable on November 25, 2025. Despite challenging market conditions and a dropped carbon sequestration lease, the company emphasized continued free cash flow generation and its focus on deleveraging while maintaining regular distributions. We'll explore how...

Wondering if Meta Platforms is truly worth its current price? You are not alone, as plenty of investors are keen to know whether there's real value or just hype behind the stock. The stock has taken a breather lately, sliding 15.1% in the past week and down 10.3% over the last month. However, it is still up an impressive 6.4% year-to-date and 14.1% over the past year. Recent headlines have revolved around Meta’s latest advancements in artificial intelligence and its push into new hardware...

PennyMac Mortgage Investment Trust (PMT) has drawn renewed attention as investors look for direction after recent price moves. With the stock’s performance showing little change over the past week, many are examining the underlying numbers for clues on future trends. See our latest analysis for PennyMac Mortgage Investment Trust. Looking at the bigger picture, PennyMac Mortgage Investment Trust’s recent share price softness follows a period of steady progress, with total shareholder returns...

Under Armour (UAA) stock has underperformed, down 32% over the past 3 months. Shares are currently trading around $4.57. This has prompted investors to reassess the company’s recent performance and outlook for value moving forward. See our latest analysis for Under Armour. After tumbling nearly 32% over the past quarter, Under Armour’s share price has lost momentum. The company capped off a year with a 47% total shareholder return decline. This ongoing weakness suggests investors are...

Wondering if Novavax is a bargain or a big risk right now? You are not alone; there is plenty of debate around whether the current price reflects the company's true value. The stock price has dropped 9.1% in the last week and 16.4% over the past month, fueling questions about both its future growth and potential risks. Recent headlines have focused on Novavax securing new funding initiatives and expanding vaccine partnerships, which has added fresh perspective (and volatility) to the share...

Curious if Ferrari’s high-octane brand translates into real stock market value? Let’s cut through the hype and answer the ultimate question: is Ferrari worth its share price right now? The last month has not been kind to Ferrari shareholders, with the stock dropping 21.8%. It is also down 17.0% over the past year, despite a doubling over three years. Recent headlines have centered on Ferrari’s moves into luxury lifestyle products and partnerships with high-profile brands. This has fueled...

Dover Corporation recently reported its third-quarter 2025 results, showing sales of US$2,077.84 million and net income of US$302 million, while also issuing full-year 2025 earnings guidance with GAAP EPS expected between US$8.06 and US$8.16 and revenue growth of 4% to 6%. Amid ongoing buyback activity earlier in the year, Dover reported higher sales but lower net income versus the previous year, offering investors fresh insight into both operational performance and forward...

NIO (NYSE:NIO) shares have seen a recent uptick, gaining 2% over the past day and 5% this week. Investors are weighing the company's steady revenue growth and sharp improvement in annual net income, while also considering lingering longer-term performance questions. See our latest analysis for NIO. After a stellar 64.9% share price return over the past 90 days, NIO’s recent gains suggest momentum is building once again, despite a setback earlier in the month. Still, with a five-year total...

Investors in Cytokinetics (CYTK) are reacting after news surfaced of a class action lawsuit claiming the company misrepresented key aspects of its aficamten drug approval timeline and related regulatory risks. See our latest analysis for Cytokinetics. Despite the recent legal headlines putting pressure on sentiment, Cytokinetics shares are still up 22.7% so far this year, supported by strong momentum from a remarkable 70.8% 90-day share price return and a five-year total shareholder return of...

Wondering if Guidewire Software might be undervalued or overheated? If you are on the hunt for value in software stocks, you probably have questions about whether Guidewire is worth a closer look right now. The stock has seen a bit of everything recently, climbing an impressive 34.5% year-to-date and 22.9% over the past year, but dropping 9.9% in the last week. That kind of movement often means investors are rethinking what Guidewire could be worth. One factor...

Fortune Brands Innovations (FBIN) shares have drifted lower lately, edging down about 4% over the past month and slipping nearly 11% over the past 3 months. Investors are watching closely as the company navigates shifting market dynamics. See our latest analysis for Fortune Brands Innovations. While Fortune Brands Innovations’ share price has slipped 25% year-to-date, recent moves reflect a gradual cooling of momentum that mirrors the company’s broader, longer-term picture. With a one-year...

On November 3, 2025, Realty Income Corporation reported third-quarter results with revenue of US$1.47 billion and net income of US$315.77 million, raising its 2025 investment volume guidance to approximately US$5.5 billion while maintaining strong rent recapture rates and updating its earnings outlook. An important insight is Realty Income's expanding investment in European markets, which now accounts for the majority of new investment volume and signals a focus on global portfolio growth...

Wondering if Chart Industries is a hidden gem or already fairly priced? You are not alone. There are plenty of signals worth digging into today. Despite a modest dip of 0.1% over the past week and 0.6% over the last month, Chart Industries has delivered an impressive 41.0% return for shareholders over the last year and a remarkable 119.1% return over five years, signaling strong long-term potential. Momentum around the stock has followed several notable deals in the industrial gas and energy...

Wondering if Fair Isaac is a hidden bargain or if its sky-high share price is actually justified? You are not alone, and today we are diving into what really drives its value. The stock has seen its ups and downs lately, sliding 2.1% over the last week and dropping 10.8% in the past month. This has contributed to a year-to-date decline of 17.3%. Despite the recent weakness, Fair Isaac has still delivered an impressive 277.8% return over three years. Market sentiment around Fair Isaac has...

Immunome (IMNM) presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, a venue where companies frequently discuss new developments in oncology research. These developments can shape investor expectations. See our latest analysis for Immunome. Immunome's momentum has noticeably picked up. Its share price jumped more than 37% over the past month and is now up over 61% for the year to date. Longer-term, its one-year total shareholder...

DoorDash (DASH) shares have drifted downward in recent weeks, slipping around 11% over the past month. Investors seem to be weighing valuation after a year of strong gains, even as the company reported double-digit annual revenue and net income growth. See our latest analysis for DoorDash. Despite some recent softness, DoorDash’s momentum this past year is hard to ignore. While the share price has pulled back roughly 11% over the past month, its year-to-date share price return remains...

Ever wondered if Ascendis Pharma is a hidden gem or if the recent buzz is justified? Let’s break down what might really be driving the current price. The stock has seen some ups and downs lately, dipping by 1.1% over the past week and 1.5% in the last month. It still boasts a strong 45.6% gain year-to-date and an impressive 59.8% return over the past year. Much of this momentum has been shaped by recent news highlighting pipeline updates and regulatory milestones, which have kept investors...

Cummins (CMI) has delivered a steady performance lately, catching the eye of investors looking for consistent industrial names. Shares have risen nearly 4% over the past week and 17% during the past 3 months. See our latest analysis for Cummins. Looking at the bigger picture, Cummins continues to build positive momentum, with a 1-year total shareholder return of 37.2% highlighting strong value creation for investors. After a solid year and with the latest share price at $437.71, the company’s...

In October 2025, The Coca-Cola Company reported strong third-quarter earnings, reaffirmed its 2025 financial guidance, completed a significant US$5.06 billion share repurchase program, and filed a shelf registration to enable flexible future capital raising or debt issuance. An important development is the nationwide 2026 relaunch of Mr. Pibb with updated packaging, a new zero sugar variant, and a marketing campaign aimed at attracting both longtime fans and new consumers from diverse...

United States Lime & Minerals (USLM) shares have edged lower over the past week, dipping 14%. Despite the recent slide, the company’s three-year return remains strong, climbing over three times from where it traded previously. See our latest analysis for United States Lime & Minerals. Despite the recent pullback, United States Lime & Minerals continues to show long-term strength, with a 1-year total shareholder return of 2.4% and an impressive 337% gain over three years. Momentum has cooled...

WESCO International recently announced third quarter 2025 results, reporting sales of US$6.20 billion and net income of US$187.5 million, while also updating its full-year guidance to an expected organic sales growth of 8% to 9%. This guidance boost, despite a year-over-year dip in net income and earnings per share, signals growing management confidence in ongoing business momentum. We’ll look at how WESCO International’s raised sales outlook enhances its investment narrative amid mixed...

GeneDx Holdings (WGS) caught attention after it reported higher quarterly revenue, raised its full-year forecast, and announced a $100 million equity offering. These moves signal shifting financial momentum and potential implications for investors. See our latest analysis for GeneDx Holdings. GeneDx Holdings’ recent upbeat earnings report and guidance upgrade have clearly energized investors. This is reflected in a 16.95% 1-month share price return and an impressive 84.01% total shareholder...

CrowdStrike Holdings (CRWD) shares have drawn interest after a stretch of solid performance. The stock has delivered a 13% gain over the past month and has continued its climb since the start of the year. See our latest analysis for CrowdStrike Holdings. Momentum is clearly building for CrowdStrike, with a 1-month share price return of nearly 13% and year-to-date gains approaching 59%. Investors are taking notice as the company continues to deliver strong total shareholder returns, up over...

Sotera Health Company released its third quarter 2025 earnings results on November 4, reporting revenue of US$311.31 million and net income of US$48.4 million, both significantly higher than the prior year period. The company’s performance highlights a material increase in profitability, with basic and diluted earnings per share from continuing operations more than doubling compared to last year. We’ll explore how these stronger earnings and revenue results impact Sotera Health’s long-term...